Publication Topic

Leighton JK, Brown P, Ellis A, Harlow P, Harrouk W, Pine PS, Robison T, Rosario L, Thompson K. 2006. Workgroup Report: Review of genomic data based on experience with mock submissions: View of the CDER Pharmacology Toxicology Nonclinical Pharmacogenomics Subcommittee. Environ Health Perspect 114:573-578; doi: 10.1289/ehp.8318. PMID: 16581548.

Ulrich K, Stern M, Goddard ME, Williams J, Zhu J, Dewar A, Painter HA, Jeffery PK, et al. 2005. Keratinocyte growth factor therapy in murine oleic acid-induced acute lung injury. Lung Cell Molec Physiol 288(6):L1179-92; doi: 10.1152/ajplung.00450.2004. PMID: 15681392.

Urban JD, Mailman RB. Functional selectivity as a mechanism of action for newer atypical antipsychotic drugs. Presented at Merck, West Point, PA, 2005.

Kim DJ, Murray I, Burns AM, Gonzalez FJ, Perdew GH, Peters JM. 2005. Peroxisome proliferator-activated receptor-beta/delta inhibits epidermal cell proliferation by down-regulation of kinase activity. J Biol Chem 280(10):9519-9527; doi: 10.1074/jbc.M413808200. PMID: 15632134.

Gay EA, Urban JD, Nichols DE, Oxford GS, Mailman RB. 2004. Functional selectivity of D2 receptor ligands in a Chinese hamster ovary hD2L cell line: Evidence for induction of ligand-specific receptor states. Mol Pharmacol 66(1):97-105; doi: 10.1124/mol.66.1.97. PMID: 15213300.

Tao L, Wadsworth S, Mercer J, Mueller C, Lynn K, Siekierka J, August A. 2002. Opposing roles of serine/threonine kinases MEKK1 and LOK in regulating the CD28 responsive element in T- cells. Biochem J 363(Pt 1):175–182; doi: 10.1042/0264-6021:3630175. PMID: 11903060.

Strobel HW, Thompson CM, Antonovic L. 2001. Cytochromes P450 in brain: Function and significance. Curr Drug Metabol 2(2):199–214; doi: 10.2174/1389200013338577. PMID: 11469726.

Choksi NY, Nix WB, Wyrick SD, Booth RG. Phenylaminotetralins activate histamine H1 receptors to stimulate dopamine synthesis in vivo in rat brain. Poster presented at the Receptor Chemistry Towards the Third Millennium – 12th Camerino-Noordwijkerhout Symposium, 1999.

Trippodo NC, Fox M, Monticello TM, Panchal BC, Asaad MM. 1999. Vasopeptidase inhibition with omapatrilat improves cardiac geometry and survival in cardiomyopathic hamsters more than does ACE inhibition with captopril. J Cardiovasc Pharmacol 34(6):782-790; doi: 10.1097/00005344-199912000-00003. PMID: 10598120.

Casale RA, Leete T, Daniels S, Jensen IS, Moyer M, Egholm M. Improvements in PNA synthesis using the Expedite Nucleic Acid Synthesis System. Large Scale Oligonucleotide Round Table, San Diego, CA, 1997.

Choksi NY, Hussain A, Booth RG. 1996. 2-Phenylaminoadenosine stimulates adenylyl cyclase activity and dopamine biosynthesis through an A2 receptor mediated mechanism. Brain Res 761(1):151–155; doi: 10.1016/s0006-8993(97)00445-9. PMID: 9247078.

Monticello TM, Sargent CA, McGill JR, Barton DS, Grover GJ. 1996. Amelioration of ischemia/reperfusion injury in isolated rat hearts by a novel ATP sensitive potassium channel opener. Cardiovasc Res 31(1):93-101; doi: 10.1016/S0008-6363(95)00167-0. PMID: 8849593.

Mathias NR, Kim KJ, Robison TW, Lee VHL. 1995. Development and characterization of rabbit tracheal epithelial cell monolayer models for drug transport studies. Pharm Res 12(10):1499-1505; doi: 10.1023/a:1016291522345. PMID: 8584489.

Cohan S, Redman D, Chen M, Wilson D, Cyr PL. 1993. Flunarazine blocks elevation of free cytosolic calcium in synaptosomes following sustained depolarization. J Cereb Blood Flow Metab 13(6):947-953; doi: 10.1038/jcbfm.1993.118. PMID: 8408319.

Youkilis E, McCartney M, Schmitt D, Woods E. 1986. Subchronic intravenous toxicity evaluation of Methionine-Enkephalin (Met-Enk). Abstract 1234, Society of Toxicology 25th Annual Meeting, New Orleans, LA, March 1986.